Abstract Library

#4446 Uncommon ophthalmic presentation of a small bowel neuroendocrine tumour: Case report

Introduction: Neuroendocrine tumours (NETs), including carcinoid tumours, are slow-growing neoplasms commonly originating in the gastrointestinal tract or bronchus, but they can also arise in other sites. Due to their indolent nature, the majority of NETs are diagnosed at an advanced stage, typically to the lymph nodes, liver, or bones.

Conference:

Presenting Author:

Authors: Hamidatou K, Behourah Z, Ahed Messaoud M, Megaiz A, Lechar M,

Keywords: Neuroendocrine tumour, Carcinoid tumour, Orbital metastasis, somatostatin analogue injection,

#3719 Outcomes of surgical treatment for small bowel neuroendocrine neoplasms – The first preliminary results of the international study group for small bowel neuroendocrine neoplasm surgery registry

Introduction: Evidence for surgical treatment of small bowel neuroendocrine neoplasms (SB-NEN) often originates from single center studies. This is the first project of international study group for small bowel neuroendocrine neoplasm surgery, aiming to build and an observational registry to facilitate future research projects and randomized clinical trials.

Conference:

Presenting Author: Kaçmaz E

Authors: Kaçmaz E, Addeo P, Hennings J, Makay �, Pasquer A,

Keywords: minimally invasive surgery, laparoscopic surgery, multicenter study, international registry, small bowel NET,

#3628 Retrospective survival analysis of patients with small bowel neuroendocrine tumors (NETs) and analysis of patient satisfaction post covid pandemic in the Sheffield European Neuroendocrine Tumor Society (ENETS) Centre of Excellence (COE)

Introduction: Small bowel NETs are the commonest primary malignancies of the small bowel. Incidence is increasing, but it is often still diagnosed at a late stage. The effects of COVID-19 may have affected patient satisfaction. Reported survival is quoted at 90% at 1 year and 70% at 5 years for all stages.

Conference:

Presenting Author:

Authors: Kwok W, Finnen J, Munir A,

Keywords: Neuroendocrine, cell, research, Neuroendocrine tumor, Survival analysis, patient satisfaction,

#3485 Small Bowel NET – Is it better to be diagnosed after long-term symptoms or acutely?

Introduction: NET patients present in many different ways and those with small bowel NET can have a particularly difficult journey to diagnosis. If this leads to a delayed diagnosis, does this also mean poorer survival and outcomes compared to those who present in another manner?

Conference:

Presenting Author:

Authors: Coldham C, Humphries S, Shah T,

Keywords: small bowel NET presentation, small bowel NET outcome,

#3239 Prevalence and presentation of Cushing and carcinoid syndromes in patients with non-metastatic primary lung neuroendocrine tumors (NETs)

Introduction: Carcinoid syndrome and Cushing syndrome are rare in non-metastatic lung NETs. In patients with small bowel NETs, carcinoid syndrome is usually associated with metastatic disease. In lung NETs, biologically active substances may be released directly into systemic circulation without inactivation in the liver or lungs.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author:

Authors: Lee K, Rakshit S, Kendi A, Wigle D, Leventakos K,

Keywords: lung neuroendocrine, carcinoid, cushing,